Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by Motownwingon Sep 05, 2017 8:18am

176 Views

Post# 26655203

RE:Anyone has the short numbers

Date	Short Sale Trades	% Total Trades	Short Traded Volume	% Total Traded Volume	Short Traded Value	% Total Traded Value
Jan 2 2017	31,759	27.983	21,037,777	20.022	$37,288,059	20.154
Jan 16 2017	12,651	26.684	7,377,516	16.436	$16,400,599	16.489
Feb 1 2017	8,398	29.192	3,224,389	14.805	$6,973,781	14.728
Feb 16 2017	10,973	31.485	4,367,795	12.857	$9,709,529	12.694
Mar 1 2017	5,838	16.701	2,947,543	9.556	$7,083,559	9.523
Mar 16 2017	1,386	5.837	1,030,830	5.407	$2,458,525	5.435
Apr 3 2017	6,594	22.544	4,074,259	15.141	$9,187,541	14.965
Apr 17 2017	6,287	33.655	2,927,129	18.646	$6,352,586	18.645
May 1 2017	4,826	27.817	2,520,257	17.032	$5,358,309	17.012
May 16 2017	3,499	21.028	1,512,126	10.402	$3,123,945	10.481
Jun 1 2017	4,562	28.399	1,897,899	16.965	$3,904,623	16.966
Jun 16 2017	4,136	23.717	2,106,645	16.872	$4,153,797	16.794
Jul 3 2017	4,812	18.737	4,894,159	17.911	$8,570,202	18.067
Jul 17 2017	3,387	19.639	2,251,595	12.511	$3,477,205	12.394
Aug 1 2017	3,813	32.682	1,516,029	16.271	$2,423,106	16.263
Aug 16 2017	5,669	27.143	3,725,571	16.704	$5,323,598	17.156
Sep 1 2017	9,584	25.485	10,270,389	20.243	$14,604,756	20.989